Ping An Biomedical Co., Ltd. engages in the provision of supply chain management services in the apparel industry delivering one-stop solutions to customers for a broad range of yarn products, textiles, and finished garments. It operates through the Yarns and Finished Garments segments. The company was founded by Yuk Yin Li and Sek Yan Ko in 2013 and is headquartered in Hong Kong.
Fundamentals
Mkt Cap
$3.19M
Volume
-
52W High
$28.56
52W Low
$1.07
PE Ratio
-
Avg. Volume
41,622.19
EPS (Annual)
-$3.85
P/B
0.31
Rev/Employee
-
Earnings
-
41
Bearish Sentiment
How do you feel about PASW?
artinB
$PASW wondering what is the reason for two days back to back 50% drop?
Made couple of day trades with small amount but watching to see if there is any news on the horizon
focafoca99
$PASW acquired three tumor-cell related patents for $2.3 M in a purchase agreement with Future Biotechnology.
focafoca99
$PASW ratifies a 40-for-1 share consolidation approved at its extraordinary general meeting.
sSwSs
$PASW — Ping An Biomedical's reverse stock split and patent acquisition contrasted with declining financials and mixed technical signals.
Upside discussed: Positive short-term price momentum indicated by 10-day EMA above 50-day SMA. Strong buying pressure suggested by a high Money Flow Index (MFI). Recent upward price movement over 7-day and 30-day periods.
Risk discussed: Significant year-over-year revenue decline of -47.4% and -62%. Negative Earnings Per Share (EPS) and Profit Margin. Weak long-term trend indicated by price below the 200-day SMA.
Recent analyses for PASW covered a 1-for-40 reverse stock split and the acquisition of oncology-related patents, alongside a strategic cooperation agreement aimed at significant sales targets. These developments were examined against a backdrop of declining revenues, negative profitability metrics, and mixed technical indicators, including short-term upward momentum contrasted with a weaker long-term trend.
Link your Stocktwits account
Ask your agent for live sentiment, watchers, trending tickers, and news.